Invention Application
- Patent Title: Nrf2 REGULATORS
-
Application No.: US17495115Application Date: 2021-10-06
-
Publication No.: US20230047296A1Publication Date: 2023-02-16
- Inventor: Jeffrey K. KERNS , James Callahan , Hongxing Yan , Thomas Daniel Heightman , Charlotte Mary Griffiths-Jones , Alison Jo-Anne Woolford , Tindy Li , Ami Lakdawala Shah , Roderick S. Davis , David Norton , Jeffrey Charles Boehm , Paris L. Hamilton , Nicole Cathleen Goodwin , Yun Jin
- Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED , ASTEX THERAPEUTICS LIMITED
- Applicant Address: GB Brentford; GB Cambridge
- Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED,ASTEX THERAPEUTICS LIMITED
- Current Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED,ASTEX THERAPEUTICS LIMITED
- Current Assignee Address: GB Brentford; GB Cambridge
- Main IPC: C07D403/10
- IPC: C07D403/10 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; C07D401/10 ; C07D403/14 ; C07D413/10 ; C07D471/04 ; C07D487/04 ; C07D498/04 ; C07D267/14 ; C07D249/18 ; C07D233/60 ; C07D487/08 ; C07D451/02 ; A61P9/00 ; A61P25/00 ; A61P11/00 ; A61P27/00 ; A61P35/00 ; A61P37/00 ; C07D233/64 ; C07D255/04 ; C07D273/01 ; C07D405/10
Abstract:
The present invention relates to aryl analogs, pharmaceutical compositions containing them and their use as NRF2 regulators.
Information query
